Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
205.00
-4.50 (-2.15%)
Aug 11, 2025, 12:50 PM CST
TPEX:3218 Market Cap
TPEX:3218 has a market cap or net worth of 17.75 billion as of August 8, 2025. Its market cap has decreased by -14.14% in one year.
Market Cap
17.75B
Enterprise Value
16.50B
Revenue
4.28B
Ranking
n/a
PE Ratio
15.85
Stock Price
207.00
Market Cap Chart
Since November 3, 2008, TPEX:3218's market cap has increased from 1.01B to 17.75B, an increase of 1,665.41%. That is a compound annual growth rate of 18.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 17.75B | 4.75% |
Dec 31, 2024 | 16.94B | -27.80% |
Dec 29, 2023 | 23.47B | -1.63% |
Dec 30, 2022 | 23.86B | 10.75% |
Dec 30, 2021 | 21.54B | 18.41% |
Dec 31, 2020 | 18.19B | 254.07% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Caliway Biopharmaceuticals | 203.96B |
PharmaEssentia | 169.97B |
Bora Pharmaceuticals Co., LTD. | 88.98B |
Lotus Pharmaceutical | 57.98B |
Oneness Biotech | 31.13B |
Polaris Group | 27.81B |
Center Laboratories | 27.03B |
Pegavision | 24.80B |